Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Sell
11,795
-2,995
-20% -$290K 0.01% 678
2026
Q1
$1.63M Hold
14,790
0.02% 609
2025
Q4
$1.67M Buy
14,790
+5,774
+64% +$698K 0.02% 614
2025
Q3
$1.31M Hold
9,016
0.01% 632
2025
Q2
$1.52M Buy
+9,016
New +$1.45M 0.02% 632
2025
Q1
Sell
-23,612
Closed -$4.01M 846
2024
Q4
$4.01M Sell
23,612
-7,576
-24% -$1.35M 0.04% 527
2024
Q3
$5.42M Hold
31,188
0.05% 462
2024
Q2
$5.36M Buy
31,188
+2,796
+10% +$575K 0.05% 464
2024
Q1
$7.4M Buy
+28,392
New +$6.44M 0.07% 407

Other funds holding NICE

Royce & Associates's NICE Position: Q2 2026 in Review

Royce & Associates reduced its Nice (NICE) stake by 20% in Q2 2026, selling an estimated $290K and leaving 11,795 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #678.

Royce & Associates first reported a position in NICE in Q1 2024 and has held it in 9 quarters since. The position peaked at $7.4M in Q1 2024. 320 funds tracked by Wall St. Rank hold NICE as of Q2 2026.

  • Royce & Associates held 11,795 shares of Nice worth $1.07M as of Q2 2026.
  • Royce & Associates sold 2,995 Nice shares in Q2 2026, an estimated $290K.
  • Nice made up 0.01% of Royce & Associates's portfolio in Q2 2026, its #678 holding.
  • Royce & Associates first reported a position in Nice in Q1 2024 and has held it in 9 quarters since.
  • Royce & Associates's Nice position peaked at $7.4M in Q1 2024.
  • 320 funds tracked by Wall St. Rank held Nice as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.